Dynacure

About:

Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.

Website: https://www.dynacure.com/

Twitter/X: dynacure

Top Investors: Andera Partners, Bpifrance, Perceptive Advisors, Idinvest Partners, Kurma Partners

Description:

Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders.